Kodiak Sciences Inc.
NASDAQ:KODBiotechnology
-$0.03 today
- Market cap
- $6.40B
- Beta
- 2.21
- P/E (TTM)
- -9.6
- EPS (TTM)
- -$3.73
Volume 0.74M
Average 1.10M
KOD Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Net Margin history
Percent of revenue · from the income statement
No Net Margin data reported for this period type.
Net Margin vs competitors
How KOD compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 27.9% | -3.5 pp | -4.2 pp | |
| LTM Jun 2026 | -3.2% | +2.4 pp | -7.2 pp | |
| LTM Mar 2026 | -182.3% | +766943.8 pp | +3271.0 pp | |
| LTM Mar 2026 | -558.2% | -235.2 pp | -375.2 pp | |
| LTM Mar 2026 | -1605.2% | -334.1 pp | +1951.5 pp | |
| LTM Mar 2026 | -3566.6% | -3304.7 pp | -492.4 pp | |
| LTM Mar 2026 | -18297.5% | -30712.4 pp | — | |
| LTM Mar 2026 | -18861.3% | — | — | |
| FY2025 | — | — | — | |
BLTEBelite Bio, Inc | FY2025 | — | — | — |
| Peer median (excluding KOD) | -1081.7% | -235.2 pp | -5.7 pp | |
Competitors are the stored peer set for KOD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 8.71M | 11M | 25.95M | 26.71M | 0 |
| Gross Profit | (8.71M) | (11M) | (25.95M) | (26.71M) | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 217.34M | 267.59M | 206.3M | 126.1M | 182.37M |
| Selling, General & Admin | 41M | 62.79M | 71.02M | 34.05M | 52.02M |
| Operating Expenses | 258.34M | 330.38M | 251.37M | 160.14M | 234.39M |
| Depreciation & Amortization | 8.71M | 11M | 25.95M | 26.71M | 26.32M |
| EBITDA | (258.26M) | (322.8M) | (234.53M) | (149.5M) | (203.65M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (267.05M) | (341.38M) | (277.32M) | (186.85M) | (234.39M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 298K | 7.07M | 16.73M | 11.15M | 4.52M |
| Interest Expense | 22K | 18K | 13K | 0 | 0 |
| Other Income / Expenses | 61K | 7.56M | 16.83M | 10.64M | 4.42M |
| Income Before Tax | (266.99M) | (333.82M) | (260.49M) | (176.21M) | (229.97M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (266.99M) | (333.82M) | (260.49M) | (176.21M) | (229.97M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (5.16) | (6.39) | (4.97) | (3.35) | (4.32) |
| EPS (Diluted) | (5.16) | (6.39) | (4.97) | (3.35) | (4.32) |
| Weighted Avg Shares | 51.79M | 52.25M | 52.41M | 52.58M | 53.21M |
| Weighted Avg Shares (Diluted) | 51.79M | 52.25M | 52.41M | 52.58M | 53.21M |
Kodiak Sciences Inc.
NASDAQ:KOD
Intrinsic Alpha fair value
Locked
Current Price
$97.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.